Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 8;150(6):296.
doi: 10.1007/s00432-024-05816-0.

Spatial transcriptomics in cancer research and potential clinical impact: a narrative review

Affiliations
Review

Spatial transcriptomics in cancer research and potential clinical impact: a narrative review

Michael A Cilento et al. J Cancer Res Clin Oncol. .

Abstract

Spatial transcriptomics (ST) provides novel insights into the tumor microenvironment (TME). ST allows the quantification and illustration of gene expression profiles in the spatial context of tissues, including both the cancer cells and the microenvironment in which they are found. In cancer research, ST has already provided novel insights into cancer metastasis, prognosis, and immunotherapy responsiveness. The clinical precision oncology application of next-generation sequencing (NGS) and RNA profiling of tumors relies on bulk methods that lack spatial context. The ability to preserve spatial information is now possible, as it allows us to capture tumor heterogeneity and multifocality. In this narrative review, we summarize precision oncology, discuss tumor sequencing in the clinic, and review the available ST research methods, including seqFISH, MERFISH (Vizgen), CosMx SMI (NanoString), Xenium (10x), Visium (10x), Stereo-seq (STOmics), and GeoMx DSP (NanoString). We then review the current ST literature with a focus on solid tumors organized by tumor type. Finally, we conclude by addressing an important question: how will spatial transcriptomics ultimately help patients with cancer?

Keywords: Genetics; Precision oncology; Solid tumors; Spatial transcriptomics; Tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Michael A Cilento: declares no potential competing interests. Christopher J Sweeney: Consulting or Advisory Role: Sanofi, Janssen, Astellas Pharma, Bayer, Genentech, Pfizer, Lilly, MDS, Point Biopharma; Research Funding: Janssen Biotech (Inst), Astellas Pharma (Inst), Sanofi (Inst), Bayer (Inst), Patents, Royalties, Other Intellectual Property: Parthenolide (Indiana University): dimethylaminoparthenolide (Leuchemix); Exelixis: Abiraterone plus cabozantinib combination; FRAS1 SNP and tristetraprolin as biomarkers of lethal prostate cancer. Stock or Other Ownership: Leuchemix. Lisa M Butler: declares no potential competing interests.

Figures

Fig. 1
Fig. 1
Complimentary bulk and spatial methods have the potential to accelerate the discovery and clinical translation of research insights from testing tumor tissue
Fig. 2
Fig. 2
Overview of spatial transcriptomic insights into solid tumors

References

    1. Al-Dalahmah O, Argenziano MG, Kannan A, Mahajan A, Furnari J, Paryani F, Boyett D, Save A, Humala N, Khan F, Li J, Lu H, Sun Y, Tuddenham JF, Goldberg AR, Dovas A, Banu MA, Sudhakar T, Bush E, Canoll P (2023) Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states. Nat Commun 14(1):2586. 10.1038/s41467-023-38186-1 - PMC - PubMed
    1. Andersson A, Larsson L, Stenbeck L, Salmén F, Ehinger A, Wu SZ, Al-Eryani G, Roden D, Swarbrick A, Borg Å, Frisén J, Engblom C, Lundeberg J (2021) Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions. Nat Commun 12(1):6012. 10.1038/s41467-021-26271-2 - PMC - PubMed
    1. André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZ, Diaz H (2020) Pembrolizumab in microsatellite-instability-high Advanced Colorectal Cancer. N Engl J Med 383(23):2207–2218. 10.1056/NEJMoa2017699. Jr - PubMed
    1. Arora R, Cao C, Kumar M, Sinha S, Chanda A, McNeil R, Samuel D, Arora RK, Matthews TW, Chandarana S, Hart R, Dort JC, Biernaskie J, Neri P, Hyrcza MD, Bose P (2023) Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat Commun 14(1):5029. 10.1038/s41467-023-40271-4 - PMC - PubMed
    1. Asp M, Bergenstråhle J, Lundeberg J (2020) Spatially resolved transcriptomes-Next Generation Tools for tissue exploration. BioEssays 42(10):e1900221. 10.1002/bies.201900221 - PubMed

MeSH terms